FDA: Balloon angioplasty catheters can reach market via 510(k) route

09/13/2010 | Medical Devices Today

The FDA issued a ruling saying manufacturers of balloon-tipped coronary angioplasty catheters can bring these products to market via the 510(k) process, rather than the premarket approval procedure, effective Oct. 8. The move is in line with the agency's decision to reclassify percutaneous transluminal coronary angioplasty catheters from Class III to Class II devices with corresponding special requirements.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA